Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
TILT Holdings Inc a global provider of cannabis business solutions that include inhalation technologies cultivation manufacturing processing brand development and retail announced today an exclusive licensing agreement of a patented stackable cartrid...
Aravive Inc a late clinicalstage oncology company developing targeted therapeutics to treat metastatic disease today announced that the US Food and Drug Administration FDA has granted Orphan Drug Designation ODD to batiraxcept for the treatment of pa...
Sunshine Biopharma Inc a pharmaceutical company offering and researching lifesaving medicines in a variety of therapeutic areas including oncology and antivirals today announced the signing of an exclusive worldwide license agreement the License Agre...
Awakn Life Sciences Corp a biotechnology company developing therapeutics to treat addiction with a nearterm focus on Alcohol Use Disorder AUD announces today it has signed its fourth Licensing Partnership agreement in North America The agreement is w...
TransCode Therapeutics Inc the RNA Oncology CompanyTM committed to more effectively treating cancer using RNA therapeutics announced today that it has received Orphan Drug Designation ODD from the US Food and Drug Administration FDA for its lead ther...
CPHI Japan opens in April as the country undergoes a huge resurgence in international trade with Western companies from Switzerland the USA and UK delivering the largest numbers of international exhibiting companies Remarkably for a pharma economy...
Peter MacCallum Cancer Centre and Cartherics Pty Ltd announced today they have entered into a Collaborative Development Program Agreement CDPA to develop Cartherics proprietary autologous CART cell therapy CTH for the treatment of ovarian cancer The...
SciSparc Ltd a specialty clinicalstage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system today announced it has signed an agreement with Israels leading and pioneer manufacturer and dist...
GC Biopharma Corp a leading provider of biopharmaceutical products in South Korea announced today that it has signed an Asset Purchase Agreement with Catalyst Biosciences NASDAQ CBIO to acquire programs related to the orphan hematology disorders Th...
Eisai Co Ltd and Biogen Inc announced today that the Biologics License Application BLA for lecanemab brand name in the US LEQEMBI an investigational antiamyloid beta A protofibril antibody has been designated for Priority Review by the National Medic...
